Cg Oncology Common Stock Pattern Recognition In Neck Pattern
| CGON Stock | 53.76 0.58 1.07% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. The In-Neck Pattern describes CG Oncology Common trend with bearish continuation signal.
CG Oncology Technical Analysis Modules
Most technical analysis of CG Oncology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CGON from various momentum indicators to cycle indicators. When you analyze CGON charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CG Oncology Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CG Oncology Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of CG Oncology Common based on widely used predictive technical indicators. In general, we focus on analyzing CGON Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CG Oncology's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of CG Oncology's intrinsic value. In addition to deriving basic predictive indicators for CG Oncology, we also check how macroeconomic factors affect CG Oncology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 164.61 | 250.28 | 225.25 | 198.8 | PTB Ratio | 13.4 | 2.44 | 2.81 | 2.67 |
Become your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cash Cows Invested few shares | |
 | Manufacturing Invested over 60 shares | |
 | Macroaxis Index Invested over 40 shares | |
 | Momentum Invested few shares | |
 | Hedge Favorites Invested over 30 shares | |
 | Impulse Invested over 200 shares | |
 | Artificial Intelligence Invested few shares | |
 | Warren Buffett Holdings Invested over 50 shares | |
 | Driverless Cars Invested over 200 shares | |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CG Oncology Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Biotechnology sector continue expanding? Could CGON diversify its offerings? Factors like these will boost the valuation of CG Oncology. Projected growth potential of CGON fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CG Oncology data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.05) | Revenue Per Share | Quarterly Revenue Growth 37.744 | Return On Assets | Return On Equity |
Investors evaluate CG Oncology Common using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CG Oncology's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause CG Oncology's market price to deviate significantly from intrinsic value.
It's important to distinguish between CG Oncology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CG Oncology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CG Oncology's market price signifies the transaction level at which participants voluntarily complete trades.